Hans Raj Bhat

2.1k total citations
84 papers, 1.7k citations indexed

About

Hans Raj Bhat is a scholar working on Organic Chemistry, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Hans Raj Bhat has authored 84 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Organic Chemistry, 13 papers in Infectious Diseases and 8 papers in Molecular Biology. Recurrent topics in Hans Raj Bhat's work include Synthesis and Characterization of Heterocyclic Compounds (55 papers), Synthesis and biological activity (37 papers) and Quinazolinone synthesis and applications (25 papers). Hans Raj Bhat is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (55 papers), Synthesis and biological activity (37 papers) and Quinazolinone synthesis and applications (25 papers). Hans Raj Bhat collaborates with scholars based in India, Spain and South Africa. Hans Raj Bhat's co-authors include Udaya Pratap Singh, Surajit Kumar Ghosh, Prashant Gahtori, Anshul Shakya, Ramendra K. Singh, Anil Prakash, Mukesh Kumar Kumawat, Kabita Gogoi, Vikas Kumar and Saumya Singh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Annals of Oncology.

In The Last Decade

Hans Raj Bhat

80 papers receiving 1.6k citations

Peers

Countries citing papers authored by Hans Raj Bhat

Since Specialization

Citations

This map shows the geographic impact of Hans Raj Bhat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Raj Bhat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Raj Bhat more than expected).

Fields of papers citing papers by Hans Raj Bhat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Raj Bhat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Raj Bhat. The network helps show where Hans Raj Bhat may publish in the future.

Co-authorship network of co-authors of Hans Raj Bhat

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Raj Bhat. A scholar is included among the top collaborators of Hans Raj Bhat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Raj Bhat. Hans Raj Bhat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular modeling, synthesis, and In Vitro evaluation of AChE and BuChE inhibitory activity of novel N-thiazole substituted coumarin derivatives 2025 ·Journal of Molecular Structure ·(unknown), Anshul Shakya, Surajit Kumar Ghosh, (unknown), (unknown), Neelutpal Gogoi, Udaya Pratap Singh, Hans Raj Bhat	0
2	In Silico Study, Synthesis, and In Vitro Evaluation of Nicotinamide-Substituted 1,3,5-Triazine Derivatives as Inhibitors of Acetylcholinesterase and Butyrylcholinesterase 2025 ·Journal of Molecular Structure ·Tutumoni Kalita, (unknown), Anshul Shakya, Surajit Kumar Ghosh, Udaya Pratap Singh, Hans Raj Bhat	1
3	In Silico Study, Synthesis, and In Vitro Evaluation of Acetylcholinesterase and Butyrylcholinesterase Inhibitory Activity of Novel N ‐Thiazole Substituted Acetamide Coumarin Derivatives 2025 ·Chemistry & Biodiversity ·(unknown), Anshul Shakya, Surajit Kumar Ghosh, (unknown), (unknown), Neelutpal Gogoi, Udaya Pratap Singh, Hans Raj Bhat	1
4	An in‐depth analysis of COVID‐19 treatment: Present situation and prospects 2024 ·Archiv der Pharmazie ·Md. Ariful Islam, Kalyani Pathak, Riya Saikia, (unknown), Aparoop Das, (unknown), Anshul Shakya, Surajit Kumar Ghosh, Udaya Pratap Singh, Hans Raj Bhat	2
5	Preclinical assessment of safety profile of hydro-alcoholic extract of Entada phaseoloides (L.) Merr. seed kernels 2023 ·South African Journal of Botany ·(unknown), Surajit Kumar Ghosh, Hans Raj Bhat, Sushil Kumar Chaudhary, Anshul Shakya	5
6	In silico screening, synthesis, and antimalarial evaluation of PABA substituted 1,3,5-triazine derivatives as Pf-DHFR inhibitors 2023 ·Experimental Parasitology ·(unknown), (unknown), (unknown), Surajit Kumar Ghosh, Anshul Shakya, (unknown), Udaya Pratap Singh, Hans Raj Bhat	5
7	Molecular docking and antimalarial evaluation of hybrid para -aminobenzoic acid 1,3,5 triazine derivatives via inhibition of Pf -DHFR 2023 ·Journal of Biomolecular Structure and Dynamics ·(unknown), (unknown), (unknown), Surajit Kumar Ghosh, Anshul Shakya, (unknown), Udaya Pratap Singh, Hans Raj Bhat	2
8	A Systematic Review on Cyclodextrin: A Versatile Tool for Enhanced Formulations and Diverse Applications 2023 ·International Journal For Multidisciplinary Research ·(unknown), (unknown), (unknown), (unknown), Hans Raj Bhat	2
9	Discovery of novel hybrids of Morpholino-1,3,5-triazine-pyrimidine as an anti-diabetic agent in High-fat, Low-dose Streptozotocin-induced diabetes in Wistar rats: An in-vitro, in-silico and in-vivo study 2023 ·Journal of Molecular Structure ·(unknown), Hans Raj Bhat, Udaya Pratap Singh	7
10	Acute and sub-chronic toxicity studies of Benincasa hispida (Thunb.) cogniaux fruit extract in rodents 2020 ·Regulatory Toxicology and Pharmacology ·Anshul Shakya, (unknown), Hans Raj Bhat, Surajit Kumar Ghosh	26
11	Ethnomedicinal Plants Used Against Diarrhea Available in Mizoram, Northeast India: A Systematic Review 2020 ·James H. Zothantluanga, (unknown), (unknown), H. Lalhlenmawia, Hans Raj Bhat, Anshul Shakya	1
12	Discovery of 1,3,5-triazine-monastrol based novel EGFR-tyrosine kinase inhibitor against human lung carcinoma 2017 ·Annals of Oncology ·Udaya Pratap Singh, (unknown), Amita Verma, Hans Raj Bhat	2
13	Discovery of novel 1,3,5-triazine-thiozolidine (DDDL-251) based dual PI3K/mTOR inhibitor against breast cancer 2017 ·Annals of Oncology ·Udaya Pratap Singh, Amita Verma, Hans Raj Bhat	1
14	Design, synthesis and antimalarial screening of some hybrid 4-aminoquinoline-triazine derivatives against pf-DHFR-TS 2016 ·Experimental Parasitology ·(unknown), Surajit Kumar Ghosh, (unknown), (unknown), Hans Raj Bhat	25
15	Design and Discovery of Pyrazole and Pyrimidine as Novel Class of Potent Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) 2014 ·AIDS Research and Human Retroviruses ·Udaya Pratap Singh, Hans Raj Bhat	2
16	Structure-guided discovery of 1,3,5-triazine–pyrazole conjugates as antibacterial and antibiofilm agent against pathogens causing human diseases with favorable metabolic fate 2014 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Hans Raj Bhat, Mukesh Kumar Kumawat, Udaya Pratap Singh	54
17	Utilisation of Home Laundry Effluent (HLE) as a catalyst for expeditious one-pot aqueous phase synthesis of highly functionalised 4-thiazolidinones 2013 ·SpringerPlus ·Udaya Pratap Singh, Hans Raj Bhat, Mukesh Kumar Kumawat, Ramendra K. Singh	2
18	Ceric ammonium nitrate (CAN) catalysed expeditious one-pot synthesis of 1,3-thiazine as IspE kinase inhibitor of Gram-negative bacteria using polyethylene glycol (PEG-400) as an efficient recyclable reaction medium 2013 ·Comptes Rendus Chimie ·Udaya Pratap Singh, Hans Raj Bhat, Ramendra K. Singh	11
19	Hybrid phenylthiazole and 1,3,5-triazine target cytosolic leucyl-tRNA synthetase for antifungal action as revealed by molecular docking studies 2013 ·In Silico Pharmacology ·Udaya Pratap Singh, Hans Raj Bhat, Prashant Gahtori, Ramendra K. Singh	17
20	Pharmacognostical and phytochemical study on the leaves of Paederia foetida linn. 2009 ·International Journal of PharmTech Research ·Vikas Kumar, (unknown), Udaya Pratap Singh, Hans Raj Bhat, Kamaruz Zaman	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact